AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Arrowhead Research Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Arrowhead Pharma

NASDAQ:ARWR

ARWR Rankings

ARWR Latest News

ARWR Latest SEC Filings

ARWR Stock Data

2.38B
120.27M
13.02%
78.91%
8.99%
Biotechnology
Pharmaceutical Preparations
United States
PASADENA